European Commission Prohibits Acquisition of GRAIL by Illumina
The European Commission has prohibited the implemented acquisition of GRAIL by Illumina under the European Union Merger Regulation. The merger will reduce choice, and stifle innovation in the emerging market for early cancer detection tests. Illumina does not offer sufficient remedies to address these concerns. Margrethe Vestager, executive vice-president of the European Commission, said that […]
Continue Reading